DEXAMBUTOL 500 mg

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire Amiens Picardie

Conditions

Is to demonstrate a non inferior efficacy of azithromycin and so the possibility for clinician to choose between two drugs for Mycobacterium avium complex treatment.Mycobacterium xenopi pulmonary infection

Phase 3

AKAPI: Amikacin Liposome Inhalation Suspension for treatment of Mycobacterium xenopi pulmonary infection: A prospective controlled open-label randomized study

RecruitingCTIS2023-506843-40-00

Centre Hospitalier Universitaire Amiens PicardieMycobacterium xenopi pulmonary infection

Start: 2025-10-29Target: 190Updated: 2025-10-24

CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections: A randomized prospective controlled study (CLAZI)

RecruitingCTIS2024-518578-15-00

Centre Hospitalier Universitaire Amiens PicardieIs to demonstrate a non inferior efficacy of azithromycin and so the possibility for clinician to choose between two drugs for Mycobacterium avium complex treatment.

Start: 2018-02-05Target: 424Updated: 2026-01-23